These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8402757)

  • 1. Noninvasive diagnosis of reperfusion in acute myocardial infarction.
    Fenster PE
    Cardiology; 1993; 82(6):365-7. PubMed ID: 8402757
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal management of acute myocardial infarction requires early and complete reperfusion.
    Kennedy JW
    Circulation; 1995 Apr; 91(7):1905-7. PubMed ID: 7895344
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed coronary angioplasty after thrombolytic therapy for acute myocardial infarction.
    Little T; Lee K; Mukherjee D; Milner M; Lindsay J; Pichard AD
    Am J Cardiol; 1990 Nov; 66(17):1259-60. PubMed ID: 2122706
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    Fresco C
    Lancet; 2003 Apr; 361(9365):1303; author reply 1304-5. PubMed ID: 12699989
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Image diagnosis].
    Ishihara M
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():468-72. PubMed ID: 12735017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute myocardial infarction: immediate coronary angioplasty for failure or contra-indications of thrombolytic therapy. Apropos of a series of 100 cases].
    Mossard JM; Arbogast R; Roman S; Baruthio J; Germain P; Roul G; Kraenner C; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):469-75. PubMed ID: 1905914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A primary report on thrombolytic therapy of acute myocardial infarction in 40 cases].
    Hu D
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Jun; 19(3):143-4, 196. PubMed ID: 1914852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
    Krucoff MW; Green CL; Langer A; Klootwijk LJ; Trollinger KM; Sawchak ST; Wilderman NM; Veldkamp RF; Pope JE; Simoons ML
    J Electrocardiol; 1993; 26 Suppl():249-55. PubMed ID: 8189133
    [No Abstract]   [Full Text] [Related]  

  • 12. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

  • 13. The open-artery theory is alive and well--again.
    Braunwald E
    N Engl J Med; 1993 Nov; 329(22):1650-2. PubMed ID: 8232436
    [No Abstract]   [Full Text] [Related]  

  • 14. [The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage].
    Staroverov II; Dundua DP; Plotnikov AN; Pomerantsev EV; Bliumental' AA; Puchkov AT; Ovasapian IuA; Serov VP; Ruda MIa
    Kardiologiia; 1993; 33(3):28-32. PubMed ID: 8377336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.
    Becker RC; Corrao JM; Harrington R; Ball SP; Gore JM
    Am Heart J; 1991 Jan; 121(1 Pt 1):220-44. PubMed ID: 1898680
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status and prospect of reperfusion therapy and PTCA in acute myocardial infarction in China].
    Chen Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Jun; 19(3):131. PubMed ID: 1914848
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty.
    Alzarka A; Haft JI; Goldstein JE
    Chest; 1990 May; 97(5):1241-2. PubMed ID: 2110053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative efficacy of pharmacoinvasive strategy of myocardial reperfusion and primary angioplasty in patients with acute ST elevation myocardial infarction].
    Markov VA; Vyshlov EV; Sevast'ianova DS; Filiushkina VIu; Dem'ianov SV; Maksimov IV; Antipov SI; Krylov AL; Varvarenko VI; Gol'tsov SG; Markov VV; Danilenko AM; Karpov RS
    Kardiologiia; 2013; 53(10):10-5. PubMed ID: 24645550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Handlin LR; Vacek JL
    Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.